Economics blog

Unit 3 Micro: Glaxo SmithKline fined $3 billion for off-label marketing

The scale of the fine is staggering, Glaxo SmithKline has been found guilty of off-label marketing - an illegal strategy - GSK targeted the antidepressant Paxil at patients under age 18 when it was approved only for adults, and promoted the drug Wellbutrin for uses it was not approved for, including weight loss and treatment of sexual dysfunction

This is corporate irresponsibility on a grand scale as this new report makes clear.

Guardian: GlaxoSmithKline fined $3bn for healthcare fraud

Daily Mail: GlaxoSmithKline to pay $3billion fine after pleading guilty to healthcare fraud - the biggest in U.S. history

News video:

See also

 

Featured
CPD courses

Teaching the New A Level Economics: Quantitative Methods

This course focuses solely on teaching & learning resources and approaches to delivering the wider range of quantitative methods contained in the new A Level and AS Level specifications. We've put together a comprehensive collection of teaching materials that will help accelerate your planning and preparation for the extended QM elements for A Level Economics.

Learn more ›

Teaching & learning products

AQA A2 Economics Worked Answers (2014)

Exemplar A Grade answers to the ECON3 and ECON4 exam papers sat in June 2014

£5.00

Edexcel AS Economics Worked Answers (2014)

Exemplar A Grade answers, with Examiner commentary, to the Edexcel AS Economics Unit 1 and Unit 2 exam papers sat in summer 2014

£5.00